National and Kapodistrian University of Athens
Παθολογοανατομική ανταπόκριση μετά από προεγχειρητική ακτινοθεραπεία στα σαρκώματα μαλακών μορίων
Abstract
dc:descriptionSoft tissue sarcomas represent a heterogeneous group of rare tumors originating from mesenchymal cells. Their primary site of occurrence include mainly the upper and lower extremities, and less frequently the trunk, head and neck, and retroperitoneal space. The management of soft tissue sarcomas involves a multimodality approach combining surgery, radiotherapy, and chemotherapy (in cases of tumors with a high risk of recurrence). Surgical resection with negative margins is the cornerstone of treatment for these tumors. Radiotherapy can be administered either before or after surgery, providing comparable outcomes but differing toxicity profiles. While postoperative radiotherapy allows for definitive histological evaluation, the pathological response to preoperative radiotherapy can serve as a prognostic indicator of clinical outcomes. However, the relationship between pathological findings in resection specimens after preoperative therapy and clinical outcomes remains unclear due to varying evaluation methods and the lack of a cut-off value for assessing the prognostic impact of pathological response. In this thesis, the pathological findings and clinical outcomes of 44 patients with localized soft tissue sarcomas of the trunk and extremities who underwent preoperative radiotherapy were studied. Specifically, the resection specimens were examined by a sarcoma-specialized pathologist, measuring viable tumor cells, necrosis, fibrosis, and hyalinization. Local relapse-free survival (LRFS), distant metastasis-free survival (DMFS), and overall survival (OS) were calculated using Kaplan–Meier survival analysis. Cox proportional hazards models were used for univariate and multivariate analysis to explore associations between clinical outcomes and pathological response. Statistical analysis of the pathological outcomes of radiotherapy revealed average rates of viable tumor cells, necrosis, and fibrosis/hyalinization of 20%, 11%, and 40%, respectively. Complete pathological response (pCR), defined as ≤5% viable tumor cells, was achieved in 25% of the cases. Local recurrence occurred in 33% of cases, with a significantly higher rate of 64% following R1 resection compared to 22% following R0 resection. Distant metastases were observed in 42% of patients, primarily in the lungs. The 3-year LRFS, DMFS, and OS rates were 65%, 54%, and 67%, respectively. Associations were identified between treatment outcomes and tumor size, grade, and histological subtype. Categorization of pathological response based on the EORTC-STBSG grading scale did not show an association with clinical outcomes. Patients achieving pCR demonstrated a lower risk of local recurrence and improved overall survival. Additionally, a literature review was conducted regarding the integration of nanoparticles in preoperative radiotherapy for soft tissue sarcomas, aiming to enhance pathological response and improve therapeutic outcomes. One phase 1 study and one phase 2/3 study were identified and analyzed. These studies focused on the use of hafnium nanoparticles in conjunction with radiotherapy, followed by surgical resection of the sarcoma. The findings of these reviews indicated that the use of hafnium nanoparticles doubled the pCR rate of preoperative radiotherapy. Since achieving pCR has been associated with improved overall survival in these patients, the use of nanoparticles in combination with preoperative radiotherapy represents a promising strategy to improve therapeutic outcomes in soft tissue sarcomas.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stergioula, Anastasia
- Στεργιούλα, Αναστασία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58588